(Q37772077)

22 August 2017

1 reference

title

Multiple sclerosis genetics--is the glass half full, or half empty? (English)

1 reference

22 August 2017

0 references

1

Jorge R Oksenberg

1 reference

22 August 2017

2

Sergio E Baranzini

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 July 2010

1 reference

22 August 2017

published in

Nature Reviews Neurology

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

429-437

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.91

22 August 2017

exact match

0 references

cites work

Risk of Multiple Sclerosis Related to Age at Immigration to Israel

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Multiple sclerosis sibling pairs: Clustered onset and familial predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The epidemiology of multiple sclerosis in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Homogeneity of active demyelinating lesions in established multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Role of return migration in the emergence of multiple sclerosis in the French West Indies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Differential twin concordance for multiple sclerosis by latitude of birthplace

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Timing of birth and risk of multiple sclerosis: population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Seasonal fluctuation of multiple sclerosis births in Sardinia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

HLA-DRB1 and month of birth in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Familial and conjugal multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

What role for genetics in the prediction of multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Risks of multiple sclerosis in relatives of patients in Flanders, Belgium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Conjugal multiple sclerosis: Population-based prevalence and recurrence risks in offspring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genetic basis for clinical expression in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Familial effects on the clinical course of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Twin concordance and sibling recurrence rates in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Concordance for multiple sclerosis in Danish twins: an update of a nationwide study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Twin studies and the heritability of MS: a conclusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

A high-density screen for linkage in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Risk alleles for multiple sclerosis identified by a genomewide study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Refining genetic associations in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Risk alleles for multiple sclerosis in multiplex families.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The expanding genetic overlap between multiple sclerosis and type I diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The role of the CD58 locus in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The genetics of autoimmune diseases: a networked perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

CD226 Gly307Ser association with multiple autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Autoimmune disease classification by inverse association with SNP alleles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The developing mosaic of autoimmune disease risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The human disease network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The modular nature of genetic diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

The biological coherence of human phenome databases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Structural variation of chromosomes in autism spectrum disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genomic copy number variation, human health, and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Copy number variation in human health, disease, and evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Copy number variation in the human genome and its implication in autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genetic mapping in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide strategies for detecting multiple loci that influence complex diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

A genomic pathway approach to a complex disease: axon guidance and Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Pathway analysis of seven common diseases assessed by genome-wide association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Common genetic variation and human traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Rare variants create synthetic genome-wide associations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Analysis of genetic inheritance in a family quartet by whole-genome sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

From genes to function: the next challenge to understanding multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Vitamin D controls T cell antigen receptor signaling and activation of human T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Immunomodulatory effects of Vitamin D in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Environmental risk factors for multiple sclerosis. Part I: The role of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

A specific viral cause of multiple sclerosis: one virus, one disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Epstein-Barr virus and multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Smoking is a risk factor for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Functional epistasis on a common MHC haplotype associated with multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

A second major histocompatibility complex susceptibility locus for multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Validating, augmenting and refining genome-wide association signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Finding the missing heritability of complex diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Age of onset in concordant twins and other relative pairs with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.91

Multiple sclerosis genetics.

31 March 2020

1 reference

12 December 2020

Familial recurrence risks and inheritance of multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis in time and space--geographic clues to cause

1 reference

12 December 2020

Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.

1 reference

12 December 2020

Familial occurrence of multiple sclerosis and its implications

1 reference

12 December 2020

Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci

1 reference

12 December 2020

Linkage strategies for genetically complex traits. I. Multilocus models

1 reference

12 December 2020

Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2010.91

1 reference

22 August 2017

1 reference